HONG KONG Prevalence CVD, including heart attack and stroke, is the third leading cause of death in Hong Kong (aft...
The Cost of Inaction: Secondary Prevention of Cardiovascular Disease in Asia-Pacific Rehabilitation ...
China based WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it ...
China based Alphamab Oncology, a clinical stage biopharmaceutical company focusing on innovative biologics medicine...
In the face of a surge in cases, rapid diagnosis and identification of high-risk patients for early intervention is cruc...
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...
The University of Oxford and China's Sichuan University have jointly launched a center to bolst...
AXA, serving customers across seven fast-growing markets including Hong Kong, mainland China, Japan, South Korea, the Ph...
Alphamab Oncology has announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd., a wholly-owned subsidiary of the Com...
China headquartered Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and co...
DocDoc Pte. Ltd., the world’s first patient intelligence company, has announced a partnership with Kaitaiming Tech...
US based company AbbVie, Harbour BioMed (HBM) with operations in US and China, Utrecht University (UU) in Europe and Era...
Junshi Biosciences, a China-based biopharmaceutical company specializing in discovery, development and commercialization...
China headquartered Luye Pharma Group held a special signing ceremony as part of the "We Care About Mental Health" initi...
Cigna’s International Markets business on 28 May 2020 in partnership with Kantar published its first Cig...
Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor...
Scientists from Hong Kong Baptist University (HKBU) have developed a novel technique that can produce pur...
Researchers from Hong Kong Baptist University (HKBU) have invented a nanostructure that can stimulate neural s...
